Windlas Biotech Limited (NSE:WINDLAS) — Market Cap & Net Worth
Market Cap & Net Worth: Windlas Biotech Limited (WINDLAS)
Windlas Biotech Limited (NSE:WINDLAS) has a market capitalization of $195.51 Million (Rs18.08 Billion) as of August 1, 2026. Listed on the NSE stock exchange, this India-based company holds position #16554 globally and #868 in its home market, demonstrating a -0.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Windlas Biotech Limited's stock price Rs857.70 by its total outstanding shares 21077239 (21.08 Million). See Windlas Biotech Limited capital spending ratio to understand how much of operating cash flow is reinvested back into capital assets.
Windlas Biotech Limited Market Cap History: 2021 to 2026
Windlas Biotech Limited's market capitalization history from 2021 to 2026. Data shows growth from $60.96 Million to $195.51 Million (16.95% CAGR).
Windlas Biotech Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Windlas Biotech Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Windlas Biotech Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.30x
Windlas Biotech Limited's market cap is 0.30 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $60.96 Million | $4.27 Billion | $158.32 Million | 0.01x | 0.39x |
| 2022 | $56.07 Million | $4.63 Billion | $380.89 Million | 0.01x | 0.15x |
| 2023 | $97.12 Million | $5.11 Billion | $426.26 Million | 0.02x | 0.23x |
| 2024 | $237.32 Million | $6.29 Billion | $581.87 Million | 0.04x | 0.41x |
| 2025 | $181.23 Million | $7.60 Billion | $609.94 Million | 0.02x | 0.30x |
Competitor Companies of WINDLAS by Market Capitalization
Companies near Windlas Biotech Limited in the global market cap rankings as of August 1, 2026.
Key companies related to Windlas Biotech Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.50 |
Windlas Biotech Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Windlas Biotech Limited's market cap moved from $60.96 Million to $ 195.51 Million, with a yearly change of 16.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs195.51 Million | +7.88% |
| 2025 | Rs181.23 Million | -23.64% |
| 2024 | Rs237.32 Million | +144.35% |
| 2023 | Rs97.12 Million | +73.21% |
| 2022 | Rs56.07 Million | -8.02% |
| 2021 | Rs60.96 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Windlas Biotech Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $195.51 Million USD |
| MoneyControl | $195.51 Million USD |
| MarketWatch | $195.51 Million USD |
| marketcap.company | $195.51 Million USD |
| Reuters | $195.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Windlas Biotech Limited
Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable an… Read more